Meng Leilei, Huang Bin, Li Rui, Wenjie Wen. CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications. // BMC Nephrology. – 2025. – DOI: 10.1186/s12882-025-04314-w. – URL: https://doi.org/10.1186/s12882-025-04314-w
Meng Leilei, Huang Bin, Li Rui, & Wenjie Wen (2025). CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications. BMC Nephrology. https://doi.org/10.1186/s12882-025-04314-w
Meng Leilei, et al. “CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications.” BMC Nephrology, 2025. doi:10.1186/s12882-025-04314-w.
@article{Leilei2025,
title = {CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications},
author = {Leilei, Meng and Bin, Huang and Rui, Li and Wen, Wenjie},
journal = {BMC Nephrology},
year = {2025},
doi = {10.1186/s12882-025-04314-w},
url = {https://doi.org/10.1186/s12882-025-04314-w}
}